首页 > 最新文献

British journal of hospital medicine最新文献

英文 中文
Impact of Co-Management Mode on Diagnosis and Treatment Compliance in Community-Level Diabetic Patients with Retinopathy. 共同管理模式对社区糖尿病视网膜病变患者诊断和治疗依从性的影响
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-14 DOI: 10.12968/hmed.2024.0216
Xia Zhang, Yanjuan Wu, Hong Shi, Hongying Wang, Xiaochun Lan, Yuezhong Ren, Yihan Tong

Aims/Background To implement a co-management mode among community-level diabetes patients and analyze its impact on diagnosis and treatment compliance and diabetic retinopathy of the patients. Methods A total of 80 patients who underwent diabetic retinopathy examination in Lanxi People's Hospital from January 2021 to March 2022 were retrospectively selected as the study objects. The clinical data of the patients were analyzed, including 40 patients who adopted the conventional diabetes management mode from January 2021 to August 2021 as the control group. From September 2021 to March 2022, 40 patients in the county medical service community diabetes management team model were adopted as the management group. The two groups of patients were compared in terms of diabetic retinopathy indictors, biochemical examination indicators, self-management ability, and nursing management satisfaction. Results Number of patients complying with treatment protocols in the management group was higher than that in the control group (p < 0.05). The blood spot area, macular thickness, hemangioma volume, and visual-field grayscale value in the management group at the last follow-up were all lower than those in the control group (p < 0.05). The levels of diastolic blood pressure (DBP), systolic blood pressure (SBP), fasting blood glucose (FBG), hemoglobin A1C (HbA1c), total cholesterol (TC), and triglyceride (TG) in the management group at the last follow-up were all lower than those in the control group (p < 0.05). The scores of disease cognition ability, self-management ability, and nursing management satisfaction in the management group were all higher than those in the control group (p < 0.05). Conclusion By changing management concept and implementing the whole-process management and treatment mode for diabetic patients within the scope of the county medical service community, the diagnosis and treatment compliance of the patients can be improved, and the effective control of blood glucose, blood pressure, and blood lipid levels can be achieved, thereby improving the self-management ability and nursing management satisfaction of the patients and providing a new nursing mode for chronic disease management.

目的/背景 在社区糖尿病患者中推行共同管理模式,并分析其对患者诊治依从性和糖尿病视网膜病变的影响。方法 回顾性选取 2021 年 1 月至 2022 年 3 月在兰溪市人民医院接受糖尿病视网膜病变检查的 80 例患者作为研究对象。分析患者的临床资料,其中将 2021 年 1 月至 2021 年 8 月采用常规糖尿病管理模式的 40 例患者作为对照组。2021 年 9 月至 2022 年 3 月,采用县级医疗服务社区糖尿病管理团队模式的 40 例患者作为管理组。比较两组患者的糖尿病视网膜病变指标、生化检查指标、自我管理能力、护理管理满意度。结果 管理组患者遵守治疗方案的人数高于对照组(P < 0.05)。管理组最后一次随访时的血斑面积、黄斑厚度、血管瘤体积和视野灰度值均低于对照组(P < 0.05)。最后一次随访时,管理组的舒张压(DBP)、收缩压(SBP)、空腹血糖(FBG)、血红蛋白 A1C(HbA1c)、总胆固醇(TC)和甘油三酯(TG)水平均低于对照组(P < 0.05)。管理组的疾病认知能力、自我管理能力和护理管理满意度评分均高于对照组(P < 0.05)。结论 通过转变管理理念,在县域医疗服务共同体范围内对糖尿病患者实施全程管理治疗模式,可提高患者的诊疗依从性,实现血糖、血压、血脂水平的有效控制,从而提高患者的自我管理能力和护理管理满意度,为慢性病管理提供一种新的护理模式。
{"title":"Impact of Co-Management Mode on Diagnosis and Treatment Compliance in Community-Level Diabetic Patients with Retinopathy.","authors":"Xia Zhang, Yanjuan Wu, Hong Shi, Hongying Wang, Xiaochun Lan, Yuezhong Ren, Yihan Tong","doi":"10.12968/hmed.2024.0216","DOIUrl":"https://doi.org/10.12968/hmed.2024.0216","url":null,"abstract":"<p><p><b>Aims/Background</b> To implement a co-management mode among community-level diabetes patients and analyze its impact on diagnosis and treatment compliance and diabetic retinopathy of the patients. <b>Methods</b> A total of 80 patients who underwent diabetic retinopathy examination in Lanxi People's Hospital from January 2021 to March 2022 were retrospectively selected as the study objects. The clinical data of the patients were analyzed, including 40 patients who adopted the conventional diabetes management mode from January 2021 to August 2021 as the control group. From September 2021 to March 2022, 40 patients in the county medical service community diabetes management team model were adopted as the management group. The two groups of patients were compared in terms of diabetic retinopathy indictors, biochemical examination indicators, self-management ability, and nursing management satisfaction. <b>Results</b> Number of patients complying with treatment protocols in the management group was higher than that in the control group (<i>p</i> < 0.05). The blood spot area, macular thickness, hemangioma volume, and visual-field grayscale value in the management group at the last follow-up were all lower than those in the control group (<i>p</i> < 0.05). The levels of diastolic blood pressure (DBP), systolic blood pressure (SBP), fasting blood glucose (FBG), hemoglobin A1C (HbA1c), total cholesterol (TC), and triglyceride (TG) in the management group at the last follow-up were all lower than those in the control group (<i>p</i> < 0.05). The scores of disease cognition ability, self-management ability, and nursing management satisfaction in the management group were all higher than those in the control group (<i>p</i> < 0.05). <b>Conclusion</b> By changing management concept and implementing the whole-process management and treatment mode for diabetic patients within the scope of the county medical service community, the diagnosis and treatment compliance of the patients can be improved, and the effective control of blood glucose, blood pressure, and blood lipid levels can be achieved, thereby improving the self-management ability and nursing management satisfaction of the patients and providing a new nursing mode for chronic disease management.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-13"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Blood Pressure Rhythm and Perioperative Blood Pressure Variability on Short-Term Prognosis in Patients with Type A Aortic Dissection. A 型主动脉夹层患者血压节律和围手术期血压变异对短期预后的影响
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-27 DOI: 10.12968/hmed.2024.0344
Yihui Wu, Hao Zhou, Weifeng Li, Suli Chen, Huajun Wang, Binbin He, Huiqin Jiang, Wenpeng Wang

Aims/Background Previous studies have indicated a strong correlation between disturbances in blood pressure (BP) circadian rhythm and major cardiovascular adverse events. Similarly, blood pressure variability (BPV) has been closely linked to cerebral small vessel disease and leukoaraiosis. This study aims to investigate the relationship between BP rhythm and BPV with the short-term prognosis of patients with Type A aortic dissection, offering insights for targeted perioperative nursing interventions and improving patient outcomes. Methods This retrospective study included patients undergoing surgical treatment for Type A aortic dissection at Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences) from June 2022 to March 2024. The study followed patients from the completion of surgery to 30 days postoperatively, with all-cause mortality within 30 days as the endpoint representing poor short-term prognosis. Clinical data were compared along with: types of BP rhythm; BPV parameters including the mean 24-hour systolic BP (24hSBP), 24-hour diastolic BP (24hDBP), and pulse pressure; and the coefficient of variability (CV) for 24hSBP, 24hDBP, and pulse pressure. Multivariate logistic regression analysis was utilized to identify risk factors for poor short-term outcomes in these patients, and receiver operating characteristic (ROC) curves were plotted to assess the predictive value of BP rhythm types and BPV indicators. Results The study ultimately included 115 participants, with 31 deaths occurring within 30 days post-surgery, resulting in a postoperative mortality rate of 26.96%. The multivariate logistic regression analysis revealed that white blood cell count, neutrophil count, non-dipping BP rhythm, pulse pressure, and the CV for 24hSBP, 24hDBP, and pulse pressure, were significant risk factors for poor short-term prognosis (p < 0.05). The ROC curve analysis demonstrated that non-dipping BP rhythm, pulse pressure, 24hSBP-CV, 24hDBP-CV, and pulse pressure-CV had areas under the curve (AUC) of 0.685, 0.749, 0.751, 0.773, and 0.763, respectively. The combination of these indicators yielded the highest AUC at 0.918. Conclusion A combination of BP rhythm and BPV indicators provides significant predictive value for poor short-term outcomes in patients with Type A aortic dissection. Clinicians and nursing staff can use these features to formulate targeted preventive measures.

目的/背景 以往的研究表明,血压昼夜节律紊乱与重大心血管不良事件之间存在密切联系。同样,血压变异性(BPV)也与脑小血管疾病和白血病密切相关。本研究旨在探讨 A 型主动脉夹层患者的血压节律和 BPV 与短期预后的关系,为围手术期有针对性的护理干预和改善患者预后提供启示。方法 该回顾性研究纳入了 2022 年 6 月至 2024 年 3 月在广东省人民医院(广东省医学科学院)接受手术治疗的 A 型主动脉夹层患者。该研究对患者从手术完成到术后 30 天进行了随访,以 30 天内全因死亡率作为终点,代表短期预后不良。临床数据与以下数据进行了比较:血压节律类型;血压变异参数,包括平均 24 小时收缩压 (24hSBP)、24 小时舒张压 (24hDBP) 和脉压;24hSBP、24hDBP 和脉压的变异系数 (CV)。利用多变量逻辑回归分析确定这些患者短期预后不良的风险因素,并绘制接收器操作特征曲线 (ROC) 以评估血压节律类型和血压变异性指标的预测价值。结果 该研究最终纳入了 115 名参与者,其中 31 人在术后 30 天内死亡,术后死亡率为 26.96%。多变量逻辑回归分析显示,白细胞计数、中性粒细胞计数、非浸没式血压节律、脉压、24hSBP、24hDBP 和脉压的 CV 是短期预后不良的显著风险因素(P < 0.05)。ROC 曲线分析表明,非浸润性血压节律、脉压、24hSBP-CV、24hDBP-CV 和脉压-CV 的曲线下面积(AUC)分别为 0.685、0.749、0.751、0.773 和 0.763。这些指标的组合产生的 AUC 最高,为 0.918。结论 结合血压节律和 BPV 指标对 A 型主动脉夹层患者的短期不良预后具有显著的预测价值。临床医生和护理人员可利用这些特征制定有针对性的预防措施。
{"title":"The Impact of Blood Pressure Rhythm and Perioperative Blood Pressure Variability on Short-Term Prognosis in Patients with Type A Aortic Dissection.","authors":"Yihui Wu, Hao Zhou, Weifeng Li, Suli Chen, Huajun Wang, Binbin He, Huiqin Jiang, Wenpeng Wang","doi":"10.12968/hmed.2024.0344","DOIUrl":"https://doi.org/10.12968/hmed.2024.0344","url":null,"abstract":"<p><p><b>Aims/Background</b> Previous studies have indicated a strong correlation between disturbances in blood pressure (BP) circadian rhythm and major cardiovascular adverse events. Similarly, blood pressure variability (BPV) has been closely linked to cerebral small vessel disease and leukoaraiosis. This study aims to investigate the relationship between BP rhythm and BPV with the short-term prognosis of patients with Type A aortic dissection, offering insights for targeted perioperative nursing interventions and improving patient outcomes. <b>Methods</b> This retrospective study included patients undergoing surgical treatment for Type A aortic dissection at Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences) from June 2022 to March 2024. The study followed patients from the completion of surgery to 30 days postoperatively, with all-cause mortality within 30 days as the endpoint representing poor short-term prognosis. Clinical data were compared along with: types of BP rhythm; BPV parameters including the mean 24-hour systolic BP (24hSBP), 24-hour diastolic BP (24hDBP), and pulse pressure; and the coefficient of variability (CV) for 24hSBP, 24hDBP, and pulse pressure. Multivariate logistic regression analysis was utilized to identify risk factors for poor short-term outcomes in these patients, and receiver operating characteristic (ROC) curves were plotted to assess the predictive value of BP rhythm types and BPV indicators. <b>Results</b> The study ultimately included 115 participants, with 31 deaths occurring within 30 days post-surgery, resulting in a postoperative mortality rate of 26.96%. The multivariate logistic regression analysis revealed that white blood cell count, neutrophil count, non-dipping BP rhythm, pulse pressure, and the CV for 24hSBP, 24hDBP, and pulse pressure, were significant risk factors for poor short-term prognosis (<i>p</i> < 0.05). The ROC curve analysis demonstrated that non-dipping BP rhythm, pulse pressure, 24hSBP-CV, 24hDBP-CV, and pulse pressure-CV had areas under the curve (AUC) of 0.685, 0.749, 0.751, 0.773, and 0.763, respectively. The combination of these indicators yielded the highest AUC at 0.918. <b>Conclusion</b> A combination of BP rhythm and BPV indicators provides significant predictive value for poor short-term outcomes in patients with Type A aortic dissection. Clinicians and nursing staff can use these features to formulate targeted preventive measures.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-13"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Top Tips for Your First Intensive Care Medicine Post as a Doctor. 作为医生首次担任重症医学职位的绝招。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-24 DOI: 10.12968/hmed.2022.0525
Isobel Pilkington, Vivien Graziadei, Hanin Ramadan, Joseph Furey, Henrik Reschreiter

An Intensive Care Medicine (ICM) rotation provides fantastic learning opportunities for doctors of all specialties. Understanding your role in this highly specialised field will assist you in gaining maximal benefit from your time in ICM while ensuring the best outcomes for your patients. It can be quite daunting reviewing deteriorating patients and admitting patients to the Intensive Care Unit (ICU). This article provides tips and advice for doctors new to the specialty, and will be a useful guide for medical, surgical, and emergency medicine trainees before they begin working in the ICU for the first time. We provide a structured, systematic framework which can be used comprehensively to assess ICU patients.

重症医学(ICM)轮转为所有专业的医生提供了绝佳的学习机会。了解自己在这一高度专业化领域中的角色,将有助于您从重症医学科的学习中获得最大收益,同时确保患者获得最佳治疗效果。对病情恶化的患者进行复查和将患者送入重症监护室 (ICU) 是一件令人生畏的事情。本文为初入该专业的医生提供了提示和建议,对于内科、外科和急诊科的受训人员来说,这将是他们首次在重症监护室工作前的有用指南。我们提供了一个结构化、系统化的框架,可用于全面评估重症监护室患者。
{"title":"Top Tips for Your First Intensive Care Medicine Post as a Doctor.","authors":"Isobel Pilkington, Vivien Graziadei, Hanin Ramadan, Joseph Furey, Henrik Reschreiter","doi":"10.12968/hmed.2022.0525","DOIUrl":"https://doi.org/10.12968/hmed.2022.0525","url":null,"abstract":"<p><p>An Intensive Care Medicine (ICM) rotation provides fantastic learning opportunities for doctors of all specialties. Understanding your role in this highly specialised field will assist you in gaining maximal benefit from your time in ICM while ensuring the best outcomes for your patients. It can be quite daunting reviewing deteriorating patients and admitting patients to the Intensive Care Unit (ICU). This article provides tips and advice for doctors new to the specialty, and will be a useful guide for medical, surgical, and emergency medicine trainees before they begin working in the ICU for the first time. We provide a structured, systematic framework which can be used comprehensively to assess ICU patients.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-12"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic Lymphocytic Thyroiditis is a Protective Factor for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Propensity Score Matching Analysis. 慢性淋巴细胞性甲状腺炎是甲状腺乳头状癌淋巴结转移的保护因素:倾向得分匹配分析
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-29 DOI: 10.12968/hmed.2024.0235
Jian Yu, Xiaoyang Li, Zhijian He, Jie He, Shangrui Rao

Aims/Background The connection between lymph node (LN) metastases in papillary thyroid carcinoma (PTC) and chronic lymphocytic thyroiditis (CLT) has been examined in a number of prior investigations. However, there is ongoing debate over the effect of CLT on LN metastasis in PTC. In order to explain the relationship between CLT and LN metastasis more convincingly, we aimed to retrospectively review clinical data to investigate the correlation between CLT and LN metastasis in PTC using propensity score matching (PSM). Methods Data on PTC patients at Wenzhou Central Hospital were collected retrospectively between 1 January 2018, and 31 March 2022. The patients were split into two groups based on whether they had CLT or not. The clinicopathological characteristics of the two groups were compared using a PSM analysis. The relationship between CLT and LN metastases was analyzed using logistic regression analysis. Results Among the 773 PTC patients collected and examined, 213 showed simultaneous CLT. Prior to PSM, patients with CLT displayed a significantly lower incidence of LN metastasis (34.3% VS 44.8%, p = 0.008), a lower metastatic LN ratio (0 (0, 0.17) VS 0 (0, 0.38), p = 0.011), and a greater number of LNs dissected (7 (5, 11) VS 5 (3, 7), p < 0.001). These differences persisted after the PSM of 208 pairs. After PSM, patients with CLT displayed a significantly lower incidence of LN metastasis (35.0% VS 44.7%, p = 0.045), a lower metastatic LN ratio (0 (0, 0.17) VS 0 (0, 0.33), p = 0.038), and a higher number of dissected LNs (7 (5, 11) VS 5 (3, 7), p ≤ 0.001). Additionally, the multivariate logistic regression analysis indicated that CLT had a protective role against LN metastasis in both the matched group (odds ratio (OR), 0.62; 95% confidence interval (CI): 0.39-0.96; p = 0.032) and the unmatched group (OR, 0.63; 95% CI: 0.44-0.91; p = 0.014). Conclusion Our data indicate that CLT may protect against LN metastases in patients with PTC. Patients having PTC with coexisting CLT have fewer LN metastases, a greater number of LNs dissected, and a lower metastatic LN ratio.

目的/背景 以前的一些研究已经探讨了甲状腺乳头状癌(PTC)淋巴结转移与慢性淋巴细胞性甲状腺炎(CLT)之间的联系。然而,关于CLT对PTC淋巴结转移的影响仍存在争议。为了更有说服力地解释CLT与LN转移之间的关系,我们旨在回顾性回顾临床数据,利用倾向评分匹配(PSM)研究PTC中CLT与LN转移之间的相关性。方法 回顾性收集温州市中心医院 2018 年 1 月 1 日至 2022 年 3 月 31 日期间的 PTC 患者数据。根据患者是否患有CLT将其分为两组。通过PSM分析比较两组患者的临床病理特征。采用逻辑回归分析法对CLT与LN转移之间的关系进行分析。结果 在收集和检查的 773 例 PTC 患者中,有 213 例同时出现 CLT。在 PSM 之前,CLT 患者的 LN 转移发生率明显较低(34.3% VS 44.8%,p = 0.008),转移 LN 比率较低(0 (0, 0.17) VS 0 (0, 0.38),p = 0.011),解剖的 LN 数量较多(7 (5, 11) VS 5 (3, 7),p < 0.001)。这些差异在对 208 对患者进行 PSM 后仍然存在。在 PSM 之后,CLT 患者的 LN 转移发生率显著降低(35.0% VS 44.7%,p = 0.045),转移 LN 比率较低(0 (0, 0.17) VS 0 (0, 0.33),p = 0.038),切除的 LN 数量较多(7 (5, 11) VS 5 (3, 7),p ≤ 0.001)。此外,多变量逻辑回归分析表明,CLT 对匹配组(比值比 (OR),0.62;95% 置信区间 (CI):0.39-0.96;P = 0.032)和非匹配组(OR,0.63;95% CI:0.44-0.91;P = 0.014)的 LN 转移均有保护作用。结论 我们的数据表明,CLT 可预防 PTC 患者的 LN 转移。合并 CLT 的 PTC 患者的 LN 转移较少,切除的 LN 数量较多,转移 LN 比率较低。
{"title":"Chronic Lymphocytic Thyroiditis is a Protective Factor for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Propensity Score Matching Analysis.","authors":"Jian Yu, Xiaoyang Li, Zhijian He, Jie He, Shangrui Rao","doi":"10.12968/hmed.2024.0235","DOIUrl":"https://doi.org/10.12968/hmed.2024.0235","url":null,"abstract":"<p><p><b>Aims/Background</b> The connection between lymph node (LN) metastases in papillary thyroid carcinoma (PTC) and chronic lymphocytic thyroiditis (CLT) has been examined in a number of prior investigations. However, there is ongoing debate over the effect of CLT on LN metastasis in PTC. In order to explain the relationship between CLT and LN metastasis more convincingly, we aimed to retrospectively review clinical data to investigate the correlation between CLT and LN metastasis in PTC using propensity score matching (PSM). <b>Methods</b> Data on PTC patients at Wenzhou Central Hospital were collected retrospectively between 1 January 2018, and 31 March 2022. The patients were split into two groups based on whether they had CLT or not. The clinicopathological characteristics of the two groups were compared using a PSM analysis. The relationship between CLT and LN metastases was analyzed using logistic regression analysis. <b>Results</b> Among the 773 PTC patients collected and examined, 213 showed simultaneous CLT. Prior to PSM, patients with CLT displayed a significantly lower incidence of LN metastasis (34.3% VS 44.8%, <i>p</i> = 0.008), a lower metastatic LN ratio (0 (0, 0.17) VS 0 (0, 0.38), <i>p</i> = 0.011), and a greater number of LNs dissected (7 (5, 11) VS 5 (3, 7), <i>p</i> < 0.001). These differences persisted after the PSM of 208 pairs. After PSM, patients with CLT displayed a significantly lower incidence of LN metastasis (35.0% VS 44.7%, <i>p</i> = 0.045), a lower metastatic LN ratio (0 (0, 0.17) VS 0 (0, 0.33), <i>p</i> = 0.038), and a higher number of dissected LNs (7 (5, 11) VS 5 (3, 7), <i>p</i> ≤ 0.001). Additionally, the multivariate logistic regression analysis indicated that CLT had a protective role against LN metastasis in both the matched group (odds ratio (OR), 0.62; 95% confidence interval (CI): 0.39-0.96; <i>p</i> = 0.032) and the unmatched group (OR, 0.63; 95% CI: 0.44-0.91; <i>p</i> = 0.014). <b>Conclusion</b> Our data indicate that CLT may protect against LN metastases in patients with PTC. Patients having PTC with coexisting CLT have fewer LN metastases, a greater number of LNs dissected, and a lower metastatic LN ratio.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-14"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rectosigmoid Endometriosis Causing Large Bowel Obstruction. 直肠乙状结肠子宫内膜异位症导致大肠梗阻
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-29 DOI: 10.12968/hmed.2024.0118
Sridhar Dharmavaram, Sudhakar Unnam, Moses Amarjothi Joacquim

Large bowel obstruction is most commonly due to colorectal carcinoma, diverticular disease or volvulus. Rare causes of large bowel obstruction like endometriosis may occur in premenopausal women and diagnosis of large bowel endometriosis can be challenging to confirm preoperatively. Hence, clinicians should maintain a high index of suspicion for rare causes of large bowel obstruction like endometriosis. This may require complete surgical resection of the involved bowel to eliminate the risk of local recurrence.

大肠梗阻最常见的病因是结肠直肠癌、憩室疾病或肠管空洞。子宫内膜异位症等导致大肠梗阻的罕见病因可能发生在绝经前妇女身上,术前确诊大肠子宫内膜异位症具有一定难度。因此,临床医生应高度怀疑子宫内膜异位症等罕见原因导致的大肠梗阻。这可能需要对受累肠道进行彻底的手术切除,以消除局部复发的风险。
{"title":"Rectosigmoid Endometriosis Causing Large Bowel Obstruction.","authors":"Sridhar Dharmavaram, Sudhakar Unnam, Moses Amarjothi Joacquim","doi":"10.12968/hmed.2024.0118","DOIUrl":"https://doi.org/10.12968/hmed.2024.0118","url":null,"abstract":"<p><p>Large bowel obstruction is most commonly due to colorectal carcinoma, diverticular disease or volvulus. Rare causes of large bowel obstruction like endometriosis may occur in premenopausal women and diagnosis of large bowel endometriosis can be challenging to confirm preoperatively. Hence, clinicians should maintain a high index of suspicion for rare causes of large bowel obstruction like endometriosis. This may require complete surgical resection of the involved bowel to eliminate the risk of local recurrence.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-7"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of SMOFlipid on Clinical Outcomes in Neonates Receiving Parenteral Nutrition: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. SMOFlipid对接受肠外营养的新生儿临床结果的影响:随机对照试验的系统回顾和元分析》。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-27 DOI: 10.12968/hmed.2024.0303
Tao He, Jianqiong Huang, Danwei Ren, Sen Yang

Aims/Background Neonatal morbidity, including various diseases such as sepsis, cholestasis, and bronchopulmonary dysplasia (BPD), is a significant concern, especially in preterm infants. Selecting the appropriate lipid emulsion in parenteral nutrition (PN) is essential to improve clinical outcomes. This analysis aimed to assess the impact of a novel composite lipid emulsion, SMOFlipid, on neonates receiving PN. Methods A systematic review and meta-analysis of randomized controlled trials (RCTs) were conducted. We compared SMOFlipid to various other lipid emulsions in PN received by infants. Research findings that addressed outcomes such as mortality, sepsis, cholestasis, necrotizing enterocolitis (NEC), BPD, patent ductus arteriosus (PDA), retinopathy of prematurity (ROP), intraventricular hemorrhage (IVH), and length of hospital stay were included. Subgroup analyses were conducted based on gestational age (GA). Twenty RCTs involving 1904 neonates were included. Results Compared to other lipid emulsions, SMOFlipid significantly reduced the cholestasis risk (risk ratio (RR): 0.65, 95% confidence interval (CI): 0.48-0.87, p = 0.004, I2 = 0%). However, the incidence related to IVH, BPD, ROP, NEC, and PDA (excluding an infant subgroup with GA <28 weeks), mortality, sepsis, and duration of hospital stay did not exhibit any substantial variations. The subgroup analysis indicated a decline in PDA incidence (RR: 0.88, 95% CI: 0.79-0.99, p = 0.04, I2 = 0%) among extremely premature infants receiving SMOFlipid. Conclusion SMOFlipid offers a promising option for neonatal PN, particularly for reducing cholestasis in preterm infants and PDA in extremely premature infants. Further investigations into its comprehensive benefits and long-term effects are warranted.

目的/背景 新生儿发病率,包括败血症、胆汁淤积症和支气管肺发育不良(BPD)等各种疾病,是一个令人严重关切的问题,尤其是早产儿。在肠外营养(PN)中选择合适的脂质乳剂对改善临床效果至关重要。本分析旨在评估新型复合脂质乳剂 SMOFlipid 对接受肠外营养的新生儿的影响。方法 对随机对照试验(RCT)进行了系统回顾和荟萃分析。我们对婴儿接受 PN 时使用的 SMOFlipid 和其他各种脂质乳剂进行了比较。研究结果包括死亡率、败血症、胆汁淤积症、坏死性小肠结肠炎(NEC)、BPD、动脉导管未闭(PDA)、早产儿视网膜病变(ROP)、脑室内出血(IVH)和住院时间。根据胎龄(GA)进行了分组分析。共纳入了 20 项研究,涉及 1904 名新生儿。结果 与其他脂质乳剂相比,SMOFlipid 能显著降低胆汁淤积的风险(风险比 (RR):0.65,95% 置信区间(CI):0.48-0.87,P = 0.004,I2 = 0%)。然而,在接受SMOFlipid治疗的极早产儿中,IVH、BPD、ROP、NEC和PDA(不包括GA亚组,P = 0.04,I2 = 0%)的发病率较低。结论 SMOFlipid为新生儿PN提供了一种很有前景的选择,尤其是在减少早产儿胆汁淤积症和极早产儿PDA方面。有必要对其综合效益和长期效果进行进一步研究。
{"title":"Impact of SMOFlipid on Clinical Outcomes in Neonates Receiving Parenteral Nutrition: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.","authors":"Tao He, Jianqiong Huang, Danwei Ren, Sen Yang","doi":"10.12968/hmed.2024.0303","DOIUrl":"10.12968/hmed.2024.0303","url":null,"abstract":"<p><p><b>Aims/Background</b> Neonatal morbidity, including various diseases such as sepsis, cholestasis, and bronchopulmonary dysplasia (BPD), is a significant concern, especially in preterm infants. Selecting the appropriate lipid emulsion in parenteral nutrition (PN) is essential to improve clinical outcomes. This analysis aimed to assess the impact of a novel composite lipid emulsion, SMOFlipid, on neonates receiving PN. <b>Methods</b> A systematic review and meta-analysis of randomized controlled trials (RCTs) were conducted. We compared SMOFlipid to various other lipid emulsions in PN received by infants. Research findings that addressed outcomes such as mortality, sepsis, cholestasis, necrotizing enterocolitis (NEC), BPD, patent ductus arteriosus (PDA), retinopathy of prematurity (ROP), intraventricular hemorrhage (IVH), and length of hospital stay were included. Subgroup analyses were conducted based on gestational age (GA). Twenty RCTs involving 1904 neonates were included. <b>Results</b> Compared to other lipid emulsions, SMOFlipid significantly reduced the cholestasis risk (risk ratio (RR): 0.65, 95% confidence interval (CI): 0.48-0.87, <i>p</i> = 0.004, I<sup>2</sup> = 0%). However, the incidence related to IVH, BPD, ROP, NEC, and PDA (excluding an infant subgroup with GA <28 weeks), mortality, sepsis, and duration of hospital stay did not exhibit any substantial variations. The subgroup analysis indicated a decline in PDA incidence (RR: 0.88, 95% CI: 0.79-0.99, <i>p</i> = 0.04, I<sup>2</sup> = 0%) among extremely premature infants receiving SMOFlipid. <b>Conclusion</b> SMOFlipid offers a promising option for neonatal PN, particularly for reducing cholestasis in preterm infants and PDA in extremely premature infants. Further investigations into its comprehensive benefits and long-term effects are warranted.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-20"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Risk Factors for Multidrug-Resistant Organism (MDRO) Infections and Construction of a Risk Prediction Model in a Cancer Specialty Hospital. 分析一家癌症专科医院耐多药生物体 (MDRO) 感染的风险因素并构建风险预测模型。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-27 DOI: 10.12968/hmed.2024.0353
Chongwei Li, Linghui He, Junwei Xu, Lili Wang, Xiaoli Cao, Hui Zhang, Pingping Ma, Yongmei Yuan

Aims/Background Patients receiving treatment in specialized cancer hospitals are particularly susceptible to multidrug-resistant organisms (MDRO) infections due to factors such as weakened immune systems caused by intensive treatments and prolonged hospital stays. This study aims to investigate the risk factors for MDRO infections in the cancer specialty hospital setting and to develop a corresponding risk prediction model. Methods Patients diagnosed with MDRO infections were selected for the MDRO infection group (n = 238), and those without for the non-MDRO infection group (n = 238). Non-parametric tests, chi-square tests, and multivariate logistic regression analysis were used to identify the primary risk factors for MDRO infections. With the aid of analysis utilizing R software 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria), we developed a nomogram prediction model, which was evaluated using the receiver operating characteristics (ROC) curve, calibration curve, and decision curve analysis (DCA). Results Age, antibiotic application time, and central venous catheterization were independent risk factors for MDRO infection (p < 0.05). The constructed nomogram prediction model for patients with MDRO infection has a C-index of 0.8640. The ROC curve results showed that the prediction model has a specificity of 0.7700, a sensitivity of 0.8800, and an area under the curve (AUC) of 0.8800. Conclusion This study identifies significant risk factors for MDRO infections in a cancer specialty hospital setting and offers a clinically useful prediction model, which may aid in targeted preventive measures and optimization of antibiotics usage, thereby potentially reducing the incidence and impact of these infections.

目的/背景 在癌症专科医院接受治疗的患者由于密集治疗和长期住院导致免疫力下降等因素,特别容易感染耐多药微生物(MDRO)。本研究旨在调查癌症专科医院环境中发生 MDRO 感染的风险因素,并建立相应的风险预测模型。方法 选择确诊感染 MDRO 的患者为 MDRO 感染组(n = 238),未感染 MDRO 的患者为非 MDRO 感染组(n = 238)。采用非参数检验、卡方检验和多变量逻辑回归分析来确定MDRO感染的主要风险因素。通过使用 R 软件 4.4.1(奥地利维也纳 R 统计计算基金会)进行分析,我们建立了一个提名图预测模型,并使用接收者操作特征(ROC)曲线、校准曲线和决策曲线分析(DCA)对该模型进行了评估。结果 年龄、抗生素应用时间和中心静脉导管插入术是 MDRO 感染的独立风险因素(P < 0.05)。所构建的 MDRO 感染患者提名图预测模型的 C 指数为 0.8640。ROC 曲线结果显示,预测模型的特异性为 0.7700,灵敏度为 0.8800,曲线下面积(AUC)为 0.8800。结论 本研究确定了在癌症专科医院环境中发生 MDRO 感染的重要风险因素,并提供了一个对临床有用的预测模型,该模型可能有助于采取有针对性的预防措施和优化抗生素的使用,从而有可能降低这些感染的发生率和影响。
{"title":"Analysis of Risk Factors for Multidrug-Resistant Organism (MDRO) Infections and Construction of a Risk Prediction Model in a Cancer Specialty Hospital.","authors":"Chongwei Li, Linghui He, Junwei Xu, Lili Wang, Xiaoli Cao, Hui Zhang, Pingping Ma, Yongmei Yuan","doi":"10.12968/hmed.2024.0353","DOIUrl":"https://doi.org/10.12968/hmed.2024.0353","url":null,"abstract":"<p><p><b>Aims/Background</b> Patients receiving treatment in specialized cancer hospitals are particularly susceptible to multidrug-resistant organisms (MDRO) infections due to factors such as weakened immune systems caused by intensive treatments and prolonged hospital stays. This study aims to investigate the risk factors for MDRO infections in the cancer specialty hospital setting and to develop a corresponding risk prediction model. <b>Methods</b> Patients diagnosed with MDRO infections were selected for the MDRO infection group (n = 238), and those without for the non-MDRO infection group (n = 238). Non-parametric tests, chi-square tests, and multivariate logistic regression analysis were used to identify the primary risk factors for MDRO infections. With the aid of analysis utilizing R software 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria), we developed a nomogram prediction model, which was evaluated using the receiver operating characteristics (ROC) curve, calibration curve, and decision curve analysis (DCA). <b>Results</b> Age, antibiotic application time, and central venous catheterization were independent risk factors for MDRO infection (<i>p</i> < 0.05). The constructed nomogram prediction model for patients with MDRO infection has a C-index of 0.8640. The ROC curve results showed that the prediction model has a specificity of 0.7700, a sensitivity of 0.8800, and an area under the curve (AUC) of 0.8800. <b>Conclusion</b> This study identifies significant risk factors for MDRO infections in a cancer specialty hospital setting and offers a clinically useful prediction model, which may aid in targeted preventive measures and optimization of antibiotics usage, thereby potentially reducing the incidence and impact of these infections.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-11"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retinal and Macular Changes in Pregnant Women of Advanced Maternal Age: A Retrospective Study. 高龄孕妇的视网膜和黄斑变化:一项回顾性研究。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-14 DOI: 10.12968/hmed.2024.0364
Xintian Liu, Yiyi Wen, Haiqing Zou, Shuangyong Wang

Aims/Background Pregnancy may cause physiological and pathological changes in multiple organs in a woman's body, including the heart, liver, and eyes. With rapid advances in societies and economies, the proportion of advanced maternal age (AMA) women has significantly increased. Here, we aimed to investigate the changes in arteriole retinal diameter, venule diameter, macular layer thickness, and arteriole to venule ratio (AVR) in this population. Methods This retrospective case-control study included 523 pregnant women (1046 eyes) and was performed on both eyes. In total, 318 subjects were included in the AMA group, and 205 subjects were included in the non-AMA group. Nonmydriatic fundus photography and optical coherence tomography (OCT) were performed on the same day, and the results were analyzed for the central retinal arteriolar equivalent (CRAE), central retinal venular equivalent (CRVE), AVR, and macular thickness (9 subfields) by integrative vessel analysis and automatic OCT software. Results In both eyes, the CRAE was significantly lower in the AMA group than that in the non-AMA group (p < 0.05; respectively). The CRVE in the AMA group was higher than that in the non-AMA group (p < 0.001; respectively). Compared to the non-AMA group, the AMA group exhibited a significant reduction in macular thickness within the inner nasal, outer nasal, and inner temporal subfields of both eyes (p < 0.05; respectively). Age was significantly correlated with CRVE and AVR in both eyes of pregnant women (CRVE: p < 0.0001; AVR: p < 0.01). Conclusion This study reports variations in the diameter of the retinal vasculature and the thickness of the macula in women of AMA. It is important to consider these changes when interpreting the adverse eye outcomes experienced by women of AMA.

目的/背景 怀孕会导致女性体内多个器官(包括心脏、肝脏和眼睛)发生生理和病理变化。随着社会和经济的快速发展,高龄产妇的比例明显增加。在此,我们旨在研究这一人群中视网膜动脉直径、静脉直径、黄斑层厚度和动脉静脉比(AVR)的变化。方法 该回顾性病例对照研究共纳入 523 名孕妇(1046 只眼睛),对双眼进行了研究。共有 318 名受试者被纳入 AMA 组,205 名受试者被纳入非 AMA 组。在同一天进行非滴眼性眼底照相和光学相干断层扫描(OCT),并通过综合血管分析和自动 OCT 软件分析视网膜中央动脉等值(CRAE)、视网膜中央静脉等值(CRVE)、视网膜反折(AVR)和黄斑厚度(9 个子视场)。结果 在双眼中,AMA 组的 CRAE 明显低于非 AMA 组(P < 0.05;分别)。AMA 组的 CRVE 高于非 AMA 组(P < 0.001;分别)。与非 AMA 组相比,AMA 组双眼鼻内侧、鼻外侧和颞内侧亚视场的黄斑厚度明显减少(分别为 p < 0.05)。年龄与孕妇双眼的 CRVE 和 AVR 有明显相关性(CRVE:p < 0.0001;AVR:p < 0.01)。结论 本研究报告了 AMA 孕妇视网膜血管直径和黄斑厚度的变化。在解释 AMA 女性眼部不良后果时,考虑这些变化非常重要。
{"title":"Retinal and Macular Changes in Pregnant Women of Advanced Maternal Age: A Retrospective Study.","authors":"Xintian Liu, Yiyi Wen, Haiqing Zou, Shuangyong Wang","doi":"10.12968/hmed.2024.0364","DOIUrl":"https://doi.org/10.12968/hmed.2024.0364","url":null,"abstract":"<p><p><b>Aims/Background</b> Pregnancy may cause physiological and pathological changes in multiple organs in a woman's body, including the heart, liver, and eyes. With rapid advances in societies and economies, the proportion of advanced maternal age (AMA) women has significantly increased. Here, we aimed to investigate the changes in arteriole retinal diameter, venule diameter, macular layer thickness, and arteriole to venule ratio (AVR) in this population. <b>Methods</b> This retrospective case-control study included 523 pregnant women (1046 eyes) and was performed on both eyes. In total, 318 subjects were included in the AMA group, and 205 subjects were included in the non-AMA group. Nonmydriatic fundus photography and optical coherence tomography (OCT) were performed on the same day, and the results were analyzed for the central retinal arteriolar equivalent (CRAE), central retinal venular equivalent (CRVE), AVR, and macular thickness (9 subfields) by integrative vessel analysis and automatic OCT software. <b>Results</b> In both eyes, the CRAE was significantly lower in the AMA group than that in the non-AMA group (<i>p</i> < 0.05; respectively). The CRVE in the AMA group was higher than that in the non-AMA group (<i>p</i> < 0.001; respectively). Compared to the non-AMA group, the AMA group exhibited a significant reduction in macular thickness within the inner nasal, outer nasal, and inner temporal subfields of both eyes (<i>p</i> < 0.05; respectively). Age was significantly correlated with CRVE and AVR in both eyes of pregnant women (CRVE: <i>p</i> < 0.0001; AVR: <i>p</i> < 0.01). <b>Conclusion</b> This study reports variations in the diameter of the retinal vasculature and the thickness of the macula in women of AMA. It is important to consider these changes when interpreting the adverse eye outcomes experienced by women of AMA.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-18"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet Reactivity with MACE in Acute Coronary Syndrome Patients Post-PCI under Dual Antiplatelet Therapy: A Meta-Analysis. 接受双联抗血小板疗法的急性冠状动脉综合征患者心导管插入术后血小板反应性与 MACE 的关系:一项 Meta 分析。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-27 DOI: 10.12968/hmed.2024.0370
Jiabing Wang, Xingliang Shi, Liuqing Chen, Ting Li, Chenttao Wu, Mingwu Hu

Aim/Background Acute coronary syndrome (ACS), a condition characterized by acute cardiac ischemia, is among the major causes of death from cardiovascular diseases (CVD). However, whether there is a correlation between platelet reactivity and major adverse cardiovascular events (MACE) remains debatable, and whether platelet function tests should be tailored for ACS patients after percutaneous coronary intervention (PCI) is still under discussion. This study aims to investigate the relationship between platelet reactivity and the occurrence of MACE in ACS patients post-PCI and to discuss the implications of these findings. Methods Clinical studies on 'PCI, ACS, dual antiplatelet therapy (DAPT), platelet reactivity, major adverse cardiovascular events (MACE)' up to 31 October 2023, were systematically collected from Embase, PubMed, and the Cochrane Library. Twelve articles meeting predefined criteria were selected. Meta-analysis was performed using Review Manager 5.4 (Cochrane, London, UK) and Stata 15.0 (StataCorp LLC, College Station, TX, USA) to compute pooled effect sizes, assess heterogeneity, explore sources of heterogeneity, and evaluate publication bias. Results Twelve articles consisting of 9297 patients were included. The meta-analysis showed that ACS patients with high platelet reactivity (HPR) who received PCI and used DAPT for 1-2 years had a greater risk of MACE (risk ratio (RR) = 1.79, 95% confidence interval (CI): 1.30-2.46) compared to those with low platelet reactivity. Moreover, greater platelet reactivity was associated independently with all-cause mortality (RR = 2.26, 95% CI: 1.63-3.12), cardiac mortality (RR = 2.87, 95% CI: 2.16-3.8), myocardial infarction (RR = 1.98, 95% CI: 1.53-2.5), in-stent restenosis (RR = 1.87, 95% CI: 1.22-2.87), as well as stroke (RR = 1.62, 95% CI: 1.02-2.57), but not with coronary revascularization events (RR = 0.99, p = 0.96, 95% CI: 0.80-1.24). On the other hand, meta-regression revealed that region (p = 0.99), type of ACS patient (p = 0.16), drug regimen (p = 0.48), testing method (p = 0.51), sampling time (p = 0.70), follow-up time (p = 0.45), and PCI protocol (p = 0.27) were not sources of heterogeneity in the study. Conclusion The meta-analysis outcomes indicate that in ACS patients receiving PCI and using dual antiplatelet therapy for 1-2 years, HPR was independently positively correlated with major adverse cardiovascular events, all-cause (or cardiac) mortality, recurrent myocardial infarction, in-stent restenosis, and stroke. This suggests that platelet reactivity testing has clinical and translational significance in predicting patients' risk of adverse cardiovascular events.

目的/背景 急性冠状动脉综合征(ACS)是一种以急性心脏缺血为特征的疾病,是心血管疾病(CVD)的主要死因之一。然而,血小板反应性与主要不良心血管事件(MACE)之间是否存在相关性仍有争议,经皮冠状动脉介入治疗(PCI)后的急性冠状动脉综合征患者是否应进行有针对性的血小板功能检测也仍在讨论之中。本研究旨在探讨经皮冠状动脉介入治疗(PCI)后 ACS 患者的血小板反应性与 MACE 发生率之间的关系,并讨论这些发现的意义。方法 系统地从 Embase、PubMed 和 Cochrane 图书馆收集了截至 2023 年 10 月 31 日有关 "PCI、ACS、双联抗血小板疗法 (DAPT)、血小板反应性、主要不良心血管事件 (MACE) "的临床研究。筛选出符合预定标准的 12 篇文章。使用Review Manager 5.4 (Cochrane, London, UK)和Stata 15.0 (StataCorp LLC, College Station, TX, USA)进行Meta分析,以计算汇集效应大小、评估异质性、探索异质性来源并评估发表偏倚。结果 共纳入12篇文章,9 297名患者。荟萃分析表明,与血小板反应性低的患者相比,接受 PCI 并使用 DAPT 1-2 年的高血小板反应性 (HPR) ACS 患者发生 MACE 的风险更高(风险比 (RR) = 1.79,95% 置信区间 (CI):1.30-2.46)。此外,较高的血小板反应性与全因死亡率(RR = 2.26,95% CI:1.63-3.12)、心脏死亡率(RR = 2.87,95% CI:2.16-3.8)、心肌梗死(RR = 1.98,95% CI:1.53-2.5)、支架内再狭窄(RR = 1.87,95% CI:1.22-2.87)以及中风(RR = 1.62,95% CI:1.02-2.57),但与冠状动脉血运重建事件无关(RR = 0.99,P = 0.96,95% CI:0.80-1.24)。另一方面,荟萃回归显示,地区(p = 0.99)、ACS 患者类型(p = 0.16)、药物方案(p = 0.48)、检测方法(p = 0.51)、取样时间(p = 0.70)、随访时间(p = 0.45)和 PCI 方案(p = 0.27)不是研究中的异质性来源。结论 荟萃分析结果表明,在接受 PCI 并使用双联抗血小板疗法 1-2 年的 ACS 患者中,HPR 与主要不良心血管事件、全因(或心源性)死亡率、复发性心肌梗死、支架内再狭窄和中风呈独立正相关。这表明血小板反应性检测在预测患者不良心血管事件风险方面具有临床和转化意义。
{"title":"Platelet Reactivity with MACE in Acute Coronary Syndrome Patients Post-PCI under Dual Antiplatelet Therapy: A Meta-Analysis.","authors":"Jiabing Wang, Xingliang Shi, Liuqing Chen, Ting Li, Chenttao Wu, Mingwu Hu","doi":"10.12968/hmed.2024.0370","DOIUrl":"10.12968/hmed.2024.0370","url":null,"abstract":"<p><p><b>Aim/Background</b> Acute coronary syndrome (ACS), a condition characterized by acute cardiac ischemia, is among the major causes of death from cardiovascular diseases (CVD). However, whether there is a correlation between platelet reactivity and major adverse cardiovascular events (MACE) remains debatable, and whether platelet function tests should be tailored for ACS patients after percutaneous coronary intervention (PCI) is still under discussion. This study aims to investigate the relationship between platelet reactivity and the occurrence of MACE in ACS patients post-PCI and to discuss the implications of these findings. <b>Methods</b> Clinical studies on 'PCI, ACS, dual antiplatelet therapy (DAPT), platelet reactivity, major adverse cardiovascular events (MACE)' up to 31 October 2023, were systematically collected from Embase, PubMed, and the Cochrane Library. Twelve articles meeting predefined criteria were selected. Meta-analysis was performed using Review Manager 5.4 (Cochrane, London, UK) and Stata 15.0 (StataCorp LLC, College Station, TX, USA) to compute pooled effect sizes, assess heterogeneity, explore sources of heterogeneity, and evaluate publication bias. <b>Results</b> Twelve articles consisting of 9297 patients were included. The meta-analysis showed that ACS patients with high platelet reactivity (HPR) who received PCI and used DAPT for 1-2 years had a greater risk of MACE (risk ratio (RR) = 1.79, 95% confidence interval (CI): 1.30-2.46) compared to those with low platelet reactivity. Moreover, greater platelet reactivity was associated independently with all-cause mortality (RR = 2.26, 95% CI: 1.63-3.12), cardiac mortality (RR = 2.87, 95% CI: 2.16-3.8), myocardial infarction (RR = 1.98, 95% CI: 1.53-2.5), in-stent restenosis (RR = 1.87, 95% CI: 1.22-2.87), as well as stroke (RR = 1.62, 95% CI: 1.02-2.57), but not with coronary revascularization events (RR = 0.99, <i>p =</i> 0.96, 95% CI: 0.80-1.24). On the other hand, meta-regression revealed that region (<i>p</i> = 0.99), type of ACS patient (<i>p</i> = 0.16), drug regimen (<i>p</i> = 0.48), testing method (<i>p</i> = 0.51), sampling time (<i>p</i> = 0.70), follow-up time (<i>p</i> = 0.45), and PCI protocol (<i>p</i> = 0.27) were not sources of heterogeneity in the study. <b>Conclusion</b> The meta-analysis outcomes indicate that in ACS patients receiving PCI and using dual antiplatelet therapy for 1-2 years, HPR was independently positively correlated with major adverse cardiovascular events, all-cause (or cardiac) mortality, recurrent myocardial infarction, in-stent restenosis, and stroke. This suggests that platelet reactivity testing has clinical and translational significance in predicting patients' risk of adverse cardiovascular events.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-17"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics and Prognostic Factors of Nephrotic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation. 同种异体造血干细胞移植后肾病综合征的临床特征和预后因素。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-24 DOI: 10.12968/hmed.2024.0356
Yan Tu, Mengni Yan, Mingming Zhang, Yi Luo, Jimin Shi, Yanmin Zhao, Rending Wang, Huiping Wang, Huarui Fu, Yamin Tan

Aims/Background Although the incidence of nephrotic syndrome (NS) following allogeneic hematopoietic stem cell transplantation (allo-HSCT) is relatively low, it can significantly affect patients' quality of life and may even be life-threatening. Therefore, it is essential to investigate the clinical manifestations and prognosis of patients with NS after allo-HSCT, as well as to identify potential high-risk factors associated with this condition. Methods We investigated the incidence rate of NS in 1457 patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) at the First Affiliated Hospital, Zhejiang University School of Medicine between June 2007 and March 2020. Among these, we identified 12 patients who developed NS after allo-HSCT (NS group). For comparison, we selected a control group of 48 patients matched by gender and transplantation time who did not develop NS. Univariate and multivariate logistic regression analyses were performed using SPSS software, version 25.0 (IBM Corp., Armonk, NY, USA) to identify independent risk factors for NS. Results Among the 1457 patients, 12 (0.82%) developed post-transplantation NS, with a median onset time of 14.99 months (range: 5.39-48.43 months) after transplantation. Univariate analysis indicated that the occurrence of post-transplantation NS was significantly correlated with total cholesterol (TC) levels at 6 months post-transplantation (p = 0.041), triglycerides (TG) and TC levels at 1 year post-transplantation (p = 0.004 and p = 0.011, respectively), and cytomegalovirus (CMV) infection (p = 0.002). Multivariate analysis revealed that CMV infection (p = 0.004, odds ratio = 15.871; 95% confidence interval: 2.465-102.194) was independently associated with the development of NS. Conclusion After allo-HSCT, NS may manifest as a form of chronic graft-versus-host disease. CMV infection is a risk factor for developing NS. Effective management through the administration of calcium inhibitors and corticosteroids can enable long-term survival in these patients.

目的/背景 虽然异基因造血干细胞移植(allo-HSCT)后肾病综合征(NS)的发病率相对较低,但它会严重影响患者的生活质量,甚至可能危及生命。因此,研究异基因造血干细胞移植后 NS 患者的临床表现和预后,并找出与此病相关的潜在高危因素至关重要。方法 我们调查了2007年6月至2020年3月期间在浙江大学医学院附属第一医院接受异基因造血干细胞移植(allo-HSCT)的1457例患者的NS发病率。其中,12 名患者在异体造血干细胞移植后出现了 NS(NS 组)。为了进行比较,我们选择了性别和移植时间相匹配的 48 例未发生 NS 的患者作为对照组。我们使用 SPSS 软件 25.0 版(IBM Corp., Armonk, NY, USA)进行了单变量和多变量逻辑回归分析,以确定导致 NS 的独立风险因素。结果 在1457例患者中,12例(0.82%)移植后出现NS,中位发病时间为移植后14.99个月(范围:5.39-48.43个月)。单变量分析表明,移植后NS的发生与移植后6个月的总胆固醇(TC)水平(p = 0.041)、移植后1年的甘油三酯(TG)和TC水平(分别为p = 0.004和p = 0.011)以及巨细胞病毒(CMV)感染(p = 0.002)显著相关。多变量分析显示,CMV 感染(p = 0.004,几率比 = 15.871;95% 置信区间:2.465-102.194)与 NS 的发生有独立关联。结论 同种异体造血干细胞移植后,NS可能表现为一种慢性移植物抗宿主疾病。CMV 感染是引发 NS 的一个风险因素。通过使用钙抑制剂和皮质类固醇进行有效治疗,可使这些患者长期存活。
{"title":"Clinical Characteristics and Prognostic Factors of Nephrotic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.","authors":"Yan Tu, Mengni Yan, Mingming Zhang, Yi Luo, Jimin Shi, Yanmin Zhao, Rending Wang, Huiping Wang, Huarui Fu, Yamin Tan","doi":"10.12968/hmed.2024.0356","DOIUrl":"https://doi.org/10.12968/hmed.2024.0356","url":null,"abstract":"<p><p><b>Aims/Background</b> Although the incidence of nephrotic syndrome (NS) following allogeneic hematopoietic stem cell transplantation (allo-HSCT) is relatively low, it can significantly affect patients' quality of life and may even be life-threatening. Therefore, it is essential to investigate the clinical manifestations and prognosis of patients with NS after allo-HSCT, as well as to identify potential high-risk factors associated with this condition. <b>Methods</b> We investigated the incidence rate of NS in 1457 patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) at the First Affiliated Hospital, Zhejiang University School of Medicine between June 2007 and March 2020. Among these, we identified 12 patients who developed NS after allo-HSCT (NS group). For comparison, we selected a control group of 48 patients matched by gender and transplantation time who did not develop NS. Univariate and multivariate logistic regression analyses were performed using SPSS software, version 25.0 (IBM Corp., Armonk, NY, USA) to identify independent risk factors for NS. <b>Results</b> Among the 1457 patients, 12 (0.82%) developed post-transplantation NS, with a median onset time of 14.99 months (range: 5.39-48.43 months) after transplantation. Univariate analysis indicated that the occurrence of post-transplantation NS was significantly correlated with total cholesterol (TC) levels at 6 months post-transplantation (<i>p</i> = 0.041), triglycerides (TG) and TC levels at 1 year post-transplantation (<i>p</i> = 0.004 and <i>p</i> = 0.011, respectively), and cytomegalovirus (CMV) infection (<i>p</i> = 0.002). Multivariate analysis revealed that CMV infection (<i>p</i> = 0.004, odds ratio = 15.871; 95% confidence interval: 2.465-102.194) was independently associated with the development of NS. <b>Conclusion</b> After allo-HSCT, NS may manifest as a form of chronic graft-versus-host disease. CMV infection is a risk factor for developing NS. Effective management through the administration of calcium inhibitors and corticosteroids can enable long-term survival in these patients.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-16"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
British journal of hospital medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1